US Stock MarketDetailed Quotes
WXXWY WUXI BIOLGCS ADR
- 3.540
- -0.180-4.84%
15min DelayClose May 3 16:00 ET
7.37BMarket Cap16.62P/E (TTM)
3.550High3.460Low53.69KVolume3.540Open3.720Pre Close189.12KTurnover0.00%Turnover Ratio16.62P/E (Static)2.08BShares13.25052wk High1.32P/B7.37BFloat Cap3.12052wk Low--Dividend TTM2.08BShs Float38.000Historical High--Div YieldTTM2.42%Amplitude3.120Historical Low3.522Avg Price1Lot Size
WUXI BIOLGCS ADR Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | (FY)Dec 31, 2018 | (FY)Dec 31, 2017 | (FY)Dec 31, 2016 | (FY)Dec 31, 2015 | (FY)Dec 31, 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | ||||||||||
| Net income from continuing operations | -22.10%4.17B | 34.18%5.36B | 103.13%3.99B | 74.48%1.97B | 52.72%1.13B | 142.92%737.72M | 72.70%303.69M | 168.87%175.85M | 33.44%65.4M | --49.01M |
| Other non cash items | -13.95%-82.89M | -61.19%-72.74M | 6.25%-45.13M | 23.93%-48.13M | 29.31%-63.27M | -448.97%-89.5M | 13.10%25.65M | 1,800.84%22.68M | 1.19%1.19M | --1.18M |
| Change In working capital | 8.02%-896.35M | -1.16%-974.47M | -162.44%-963.33M | -67.96%-367.06M | 11.07%-218.54M | -115.20%-245.74M | 44.69%-114.19M | -417.25%-206.44M | 47.05%-39.91M | ---75.38M |
| -Change in receivables | 45.79%-864.34M | 19.86%-1.59B | -42.74%-1.99B | -157.87%-1.39B | -13.14%-540.44M | -135.21%-477.66M | -42.77%-203.08M | -29.08%-142.24M | 4.05%-110.19M | ---114.85M |
| -Change in inventory | 188.83%442.46M | 36.40%-498.12M | -11.17%-783.19M | -649.45%-704.52M | 1.75%-94.01M | 7.68%-95.68M | -102.64%-103.64M | 49.44%-51.15M | -163.47%-101.16M | ---38.4M |
| -Change in prepaid assets | 187.74%5.07M | -69.61%-5.78M | 13.12%-3.41M | -222.17%-3.92M | 87.52%-1.22M | 14.26%-9.76M | ---11.38M | --0 | ---- | ---- |
| -Change in other current assets | -119.43%-317.2M | 52.49%1.63B | 8.39%1.07B | 707.90%987.85M | -205.62%-162.5M | --153.85M | --0 | ---- | 72.52%-16.81M | ---61.17M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -15.77%4.67B | 61.51%5.54B | 82.39%3.43B | 55.72%1.88B | 58.62%1.21B | 111.39%761.61M | 339.79%360.28M | -23.55%81.92M | 398.26%107.15M | --21.51M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Net PPE purchase and sale | 31.20%-4.02B | 9.22%-5.85B | -8.12%-6.44B | -87.03%-5.96B | -137.74%-3.19B | -99.84%-1.34B | -56.35%-670.55M | -28.29%-428.88M | -555.51%-334.3M | ---51M |
| Net intangibles purchase and sale | ---10M | --0 | ---- | ---- | 99.76%-1.19M | -2,760.21%-489.9M | ---17.13M | --0 | ---- | ---- |
| Net business purchase and sale | --0 | 88.91%-281.04M | -1,533.05%-2.54B | 48.39%-155.24M | ---300.82M | --0 | ---- | ---- | ---- | ---- |
| Net investment purchase and sale | 294.21%555.32M | 72.93%-285.94M | 4.27%-1.06B | -51.56%-1.1B | -156.98%-728M | 182.47%1.28B | ---1.55B | --0 | ---- | ---- |
| Net other investing changes | -89.30%41.44M | 23.34%387.22M | 1,220.80%313.95M | 91.56%-28.01M | -686.76%-331.72M | 175.47%56.53M | 165.19%20.52M | 503.07%7.74M | -318.68%-1.92M | --878K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 45.36%-3.23B | 38.47%-5.91B | -33.06%-9.6B | -60.58%-7.22B | -980.08%-4.49B | 81.20%-416.07M | -425.53%-2.21B | -25.26%-421.14M | -570.82%-336.22M | ---50.12M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | ||||||||||
| Net issuance payments of debt | -305.18%-704.75M | -228.28%-173.93M | -106.09%-52.98M | -54.42%870.46M | --1.91B | --0 | -272.05%-1.08B | 56.15%625.34M | 4,353.79%400.49M | --8.99M |
| Net common stock issuance | 67.82%-890.76M | -132.50%-2.77B | 50.79%8.52B | 57.07%5.65B | 11.50%3.6B | -9.73%3.23B | --3.57B | --0 | --0 | --24M |
| Cash dividends paid | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---18.06M | ---- |
| Net other financing activities | 571.32%3.89B | --579.94M | ---- | --216.89M | ---- | 100.72%600K | 66.74%-83.33M | -9,939.76%-250.49M | ---2.5M | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 175.67%1.96B | -131.57%-2.59B | 25.04%8.21B | 21.30%6.57B | 68.79%5.41B | 43.85%3.21B | 569.94%2.23B | -11.83%332.76M | 1,139.98%377.4M | --30.44M |
| Net cash flow | ||||||||||
| Beginning cash position | -28.97%6.4B | 26.88%9B | 14.35%7.1B | 51.93%6.21B | 710.59%4.08B | 197.97%503.88M | 6.87%169.1M | 2,560.21%158.23M | 42.43%5.95M | --4.18M |
| Current changes in cash | 214.96%3.4B | -245.08%-2.96B | 65.69%2.04B | -42.14%1.23B | -40.13%2.13B | 843.93%3.55B | 5,925.63%376.34M | -104.36%-6.46M | 8,045.74%148.33M | --1.82M |
| Effect of exchange rate changes | -135.99%-125.99M | 366.24%350.11M | 61.37%-131.5M | -5,697.96%-340.4M | -120.85%-5.87M | 167.76%28.16M | -339.76%-41.56M | 339.14%17.33M | 8,155.10%3.95M | ---49K |
| End cash Position | 51.20%9.67B | -28.97%6.4B | 26.88%9B | 14.35%7.1B | 51.93%6.21B | 710.59%4.08B | 197.97%503.88M | 6.87%169.1M | 2,560.21%158.23M | --5.95M |
| Free cash flow | 233.82%437.2M | 89.43%-326.72M | 25.38%-3.09B | -104.46%-4.14B | -89.60%-2.03B | -226.43%-1.07B | 5.62%-327.45M | -52.70%-346.96M | -669.19%-227.21M | ---29.54M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg